Results 251 to 260 of about 730,852 (352)

Exploring role of genetics in diagnosing, management, and outcome of infantile epilepsy: A case series of three interesting cases. [PDF]

J Family Med Prim Care
Kadian J, Yadav D, Alhan P, Bhagwan J, Yadav D, Bhalla K.   +5 more
europepmc   +1 more source

WONOEP 2022: Neurotechnology for the diagnosis of epilepsy [PDF]

Konrad Wagstyl, Katja Kobow, Pablo M. Casillas‐Espinosa, Andrew J. Cole, Diego Jiménez‐Jiménez, Hiroki Nariai, Stéphanie Baulac, Terence J. O’Brien, David C. Henshall, Özlem Akman, Raman Sankar, Aristea S. Galanopoulou, Stéphane Auvin   +12 more
openalex   +1 more source

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono, Bruce A.C. Cree, Stephen L. Hauser, Sergio E. Baranzini   +3 more
wiley   +1 more source

Epilepsy-Induced Neurodegeneration and Its Therapeutic Interventions. [PDF]

Cureus
Kaddoura S, Banerjee A, Ganti L.
europepmc   +1 more source

Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade‐Long Longitudinal Analysis

Annals of Neurology, EarlyView.
Objective Wearable technology allows accurate measurement of turning while walking, with cross‐sectional studies indicating that difficulty turning presents even in preclinical phases of Parkinson's disease. The aim of our study was to quantify rate of change of turning performance in a cohort of older adults, and test whether turning decline can ...
Morad Elshehabi, Clint Hansen, Markus A. Hobert, Anna‐Katharina von Thaler, Kathrin Brockmann, Bhargav Tallapragada, Florian Metzger, Daniela Berg, Walter Maetzler, Brook Galna   +9 more
wiley   +1 more source

Functional Resection of the Mesial Temporal Lobe in Drug-Resistant Epilepsy: Case Report and Multidisciplinary Review

Isis Franco Martin, Talita Sousa Brito, Jorge Lima, Thiago Bonafé, Matheus Souza Ribeiro, Marco Antonio Oliveira Santos Junio, Isadora Luiza Babinschi Dias de Souza, Ernestina Santos   +7 more
openalex   +2 more sources

Pro‐Inflammatory c‐Met+ CD4 T Cells in Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective Hepatocyte growth factor (HGF) binds exclusively the c‐Met surface receptor, and the HGF/c‐Met axis regulates T cell function in autoimmune diseases. We analyzed c‐Met expression on human CD4 T cells in the blood and cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) versus non‐inflammatory neurological disease (NIND), to ...
Gautier Breville, Mahdia Benkhoucha, Ayman Rezk, Ngoc Lan Tran, Isis Senoner, Amit Bar‐Or, Patrice H. Lalive   +6 more
wiley   +1 more source

Is Cardiovascular Mortality Among People with Epilepsy increasing? A retrospective US population study. [PDF]

BMJ Open
Curtis A, Markovic D, Liao A, Ganapa S, Gaertner M, DeGiorgio CM.   +5 more
europepmc   +1 more source

Back Again to the Future: A New Era for Cerebroprotection

Annals of Neurology, EarlyView.
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley   +1 more source

Unlocking Comprehensive Epilepsy Care: The Dual Promise of Magnetoencephalography. [PDF]

J Epilepsy Res
Kim DW.
europepmc   +1 more source